- Investing Ideas
- U.S. Pharmaceuticals & Biotech Upcoming Dividends
U.S. Pharmaceuticals & Biotech Upcoming Dividends
Results
7
Companies which have announced upcoming dividend payments.
7 companies
Bristol-Myers Squibb
Market Cap: US$122.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$60.17
7D
2.6%
1Y
22.2%
Johnson & Johnson
Market Cap: US$564.0b
Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ
US$234.18
7D
-1.8%
1Y
48.7%
Zoetis
Market Cap: US$51.5b
Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
ZTS
US$122.38
7D
3.8%
1Y
-17.7%
Amgen
Market Cap: US$191.8b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$355.30
7D
1.2%
1Y
28.1%
AbbVie
Market Cap: US$368.6b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$208.38
7D
0.2%
1Y
20.5%
Agilent Technologies
Market Cap: US$34.4b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$121.87
7D
5.9%
1Y
18.9%
Danaher
Market Cap: US$137.8b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
DHR
US$194.75
7D
2.7%
1Y
4.2%